This is not the most recent version of the article. View current version (17 FEB 2017)

Intervention Review

Propranolol for migraine prophylaxis

  1. Klaus Linde1,
  2. Karin Rossnagel2

Editorial Group: Cochrane Pain, Palliative and Supportive Care Group

Published Online: 19 APR 2004

Assessed as up-to-date: 15 MAY 2003

DOI: 10.1002/14651858.CD003225.pub2


How to Cite

Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD003225. DOI: 10.1002/14651858.CD003225.pub2.

Author Information

  1. 1

    Technical University Munich, Centre for Complementary Medicine Research, Department of Internal Medicine II, Munich, Germany

  2. 2

    Charité University Hospital, Institute of Social Medicine & Epidemiology, Berlin, Germany

*Anna Hobson, Cochrane Pain, Palliative and Supportive Care Group, Pain Research Unit, The Churchill Hospital, Old Road, Oxford, OX3 7LE, UK. anna.hobson@ndcn.ox.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2004

SEARCH

This is not the most recent version of the article. View current version (17 FEB 2017)

  1. Current Version

    Propranolol for migraine prophylaxis

    Klaus Linde and Karin Rossnagel

    Version of Record online: 17 FEB 2017 | DOI: 10.1002/14651858.CD003225.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Propranolol for migraine prophylaxis

    Klaus Linde and Karin Rossnagel

    Version of Record online: 19 APR 2004 | DOI: 10.1002/14651858.CD003225.pub2

  2. Version 1

    Propranolol for migraine prophylaxis

    K Linde, K Rossnagel, HJ Jaster and SN Willich

    Version of Record online: 18 MAY 2001 | DOI: 10.1002/14651858.CD003225